BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28345006)

  • 1. Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor Modification.
    Knipping F; Osborn MJ; Petri K; Tolar J; Glimm H; von Kalle C; Schmidt M; Gabriel R
    Mol Ther Methods Clin Dev; 2017 Mar; 4():213-224. PubMed ID: 28345006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of gene editing efficiencies of CRISPR/Cas9 and TALEN for generation of MSTN knock-out cashmere goats.
    Zhang J; Liu J; Yang W; Cui M; Dai B; Dong Y; Yang J; Zhang X; Liu D; Liang H; Cang M
    Theriogenology; 2019 Jul; 132():1-11. PubMed ID: 30981084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homologous recombination-mediated targeted integration in monkey embryos using TALE nucleases.
    Chu C; Yang Z; Yang J; Yan L; Si C; Kang Y; Chen Z; Chen Y; Ji W; Niu Y
    BMC Biotechnol; 2019 Jan; 19(1):7. PubMed ID: 30646876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of genome editing technologies to the study and treatment of hematological disease.
    Pellagatti A; Dolatshad H; Yip BH; Valletta S; Boultwood J
    Adv Biol Regul; 2016 Jan; 60():122-134. PubMed ID: 26433620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of end-joining repair for efficient site-specific gene insertion after TALEN/CRISPR mutagenesis in Aedes aegypti.
    Basu S; Aryan A; Overcash JM; Samuel GH; Anderson MA; Dahlem TJ; Myles KM; Adelman ZN
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4038-43. PubMed ID: 25775608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of CRISPR/Cas9 and TALENs on editing an integrated EGFP gene in the genome of HEK293FT cells.
    He Z; Proudfoot C; Whitelaw CB; Lillico SG
    Springerplus; 2016; 5(1):814. PubMed ID: 27390654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted mutagenesis in Zea mays using TALENs and the CRISPR/Cas system.
    Liang Z; Zhang K; Chen K; Gao C
    J Genet Genomics; 2014 Feb; 41(2):63-8. PubMed ID: 24576457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection.
    Cottle RN; Lee CM; Archer D; Bao G
    Sci Rep; 2015 Nov; 5():16031. PubMed ID: 26558999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted mutagenesis of aryl hydrocarbon receptor 2a and 2b genes in Atlantic killifish (Fundulus heteroclitus).
    Aluru N; Karchner SI; Franks DG; Nacci D; Champlin D; Hahn ME
    Aquat Toxicol; 2015 Jan; 158():192-201. PubMed ID: 25481785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9.
    Du H; Zeng X; Zhao M; Cui X; Wang Q; Yang H; Cheng H; Yu D
    J Biotechnol; 2016 Jan; 217():90-7. PubMed ID: 26603121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the editing patterns and editing efficiencies of TALEN and CRISPR-Cas9 when targeting the human CCR5 gene.
    Nerys-Junior A; Braga-Dias LP; Pezzuto P; Cotta-de-Almeida V; Tanuri A
    Genet Mol Biol; 2018; 41(1):167-179. PubMed ID: 29583154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
    Guha TK; Edgell DR
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish.
    Auer TO; Del Bene F
    Methods; 2014 Sep; 69(2):142-50. PubMed ID: 24704174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homology-Independent Integration of Plasmid DNA into the Zebrafish Genome.
    Auer TO; Del Bene F
    Methods Mol Biol; 2016; 1451():31-51. PubMed ID: 27464799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-Specific Integration of Exogenous Genes Using Genome Editing Technologies in Zebrafish.
    Kawahara A; Hisano Y; Ota S; Taimatsu K
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
    Eid A; Mahfouz MM
    Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome Editing With TALEN, CRISPR-Cas9 and CRISPR-Cas12a in Combination With AAV6 Homology Donor Restores T Cell Function for XLP.
    Houghton BC; Panchal N; Haas SA; Chmielewski KO; Hildenbeutel M; Whittaker T; Mussolino C; Cathomen T; Thrasher AJ; Booth C
    Front Genome Ed; 2022; 4():828489. PubMed ID: 35677600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of microhomologous-mediated site-specific integrated LacS gene cow using TALENs.
    Su X; Wang S; Su G; Zheng Z; Zhang J; Ma Y; Liu Z; Zhou H; Zhang Y; Zhang L
    Theriogenology; 2018 Oct; 119():282-288. PubMed ID: 30075414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.